Congenital myopathies – centronuclear myopathies

In this study, we investigated whether DYN101-m could also reverse disease phenotypes in Dnm2RW/+ mice in a dose-dependent manner.

Source: Neuromuscular Disorders - September 19, 2021 Category: Neurology Authors: M. Depla, A. Rob é, S. Buono, C. Koch, M. Bitoun, S. Colombo, B. Cowling Source Type: research